196 related articles for article (PubMed ID: 33226623)
21. Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency.
Yamakawa T; Sato Y; Matsumura Y; Kobayashi Y; Kawamura Y; Goshima N; Yamanaka S; Okita K
Stem Cells; 2016 Nov; 34(11):2661-2669. PubMed ID: 27335261
[TBL] [Abstract][Full Text] [Related]
22. Induced pluripotent stem cells from goat fibroblasts.
Song H; Li H; Huang M; Xu D; Gu C; Wang Z; Dong F; Wang F
Mol Reprod Dev; 2013 Dec; 80(12):1009-17. PubMed ID: 24123501
[TBL] [Abstract][Full Text] [Related]
23. Identification of Oct4-activating compounds that enhance reprogramming efficiency.
Li W; Tian E; Chen ZX; Sun G; Ye P; Yang S; Lu D; Xie J; Ho TV; Tsark WM; Wang C; Horne DA; Riggs AD; Yip ML; Shi Y
Proc Natl Acad Sci U S A; 2012 Dec; 109(51):20853-8. PubMed ID: 23213213
[TBL] [Abstract][Full Text] [Related]
24. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
[TBL] [Abstract][Full Text] [Related]
25. Human-induced pluripotent stem cells produced under xeno-free conditions.
Ross PJ; Suhr ST; Rodriguez RM; Chang EA; Wang K; Siripattarapravat K; Ko T; Cibelli JB
Stem Cells Dev; 2010 Aug; 19(8):1221-9. PubMed ID: 20030562
[TBL] [Abstract][Full Text] [Related]
26. Optimized surface markers for the prospective isolation of high-quality hiPSCs using flow cytometry selection.
Abujarour R; Valamehr B; Robinson M; Rezner B; Vranceanu F; Flynn P
Sci Rep; 2013; 3():1179. PubMed ID: 23378912
[TBL] [Abstract][Full Text] [Related]
27. Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.
Bazley FA; Liu CF; Yuan X; Hao H; All AH; De Los Angeles A; Zambidis ET; Gearhart JD; Kerr CL
Stem Cells Dev; 2015 Nov; 24(22):2634-48. PubMed ID: 26154167
[TBL] [Abstract][Full Text] [Related]
28. Early reprogramming regulators identified by prospective isolation and mass cytometry.
Lujan E; Zunder ER; Ng YH; Goronzy IN; Nolan GP; Wernig M
Nature; 2015 May; 521(7552):352-6. PubMed ID: 25830878
[TBL] [Abstract][Full Text] [Related]
29. Reprogramming Human Fibroblasts to Induced Pluripotent Stem Cells Using the GFP-Marked Lentiviral Vectors in the Chemically Defined Medium.
Shao Z; Cevallos RR; Hu K
Methods Mol Biol; 2021; 2239():101-116. PubMed ID: 33226615
[TBL] [Abstract][Full Text] [Related]
30. Comparison of two different culture conditions for derivation of early hiPSC.
Hey CAB; Saltõkova KB; Bisgaard HC; Møller LB
Cell Biol Int; 2018 Nov; 42(11):1467-1473. PubMed ID: 29603519
[TBL] [Abstract][Full Text] [Related]
31. Expression level of pluripotent genes in incomplete reprogramming.
Zhao X; Li Q; Jiang WM; Liu HY; Ma N; Zhou Z; Li LJ; Huang YH; Ma YL
Asian Pac J Trop Med; 2014 Aug; 7(8):639-644. PubMed ID: 25149378
[TBL] [Abstract][Full Text] [Related]
32. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
33. Regional differences in expression of specific markers for human embryonic stem cells.
Laursen SB; Møllgård K; Olesen C; Oliveri RS; Brøchner CB; Byskov AG; Andersen AN; Høyer PE; Tommerup N; Yding Andersen C
Reprod Biomed Online; 2007 Jul; 15(1):89-98. PubMed ID: 17623545
[TBL] [Abstract][Full Text] [Related]
34. Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog.
Moon JH; Yun W; Kim J; Hyeon S; Kang PJ; Park G; Kim A; Oh S; Whang KY; Kim DW; Yoon BS; You S
Biochem Biophys Res Commun; 2013 Feb; 431(3):444-9. PubMed ID: 23333380
[TBL] [Abstract][Full Text] [Related]
35. Generation of Systemic Lupus Erythematosus Patient-Derived Induced Pluripotent Stem Cells from Blood.
Li W; Liu D; Zheng F; Zeng Z; Cai W; Luan S; Hong X; Tang D; Yin LH; Dai Y
Stem Cells Dev; 2021 Mar; 30(5):227-233. PubMed ID: 33397195
[TBL] [Abstract][Full Text] [Related]
36. Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs.
Velychko S; Adachi K; Kim KP; Hou Y; MacCarthy CM; Wu G; Schöler HR
Cell Stem Cell; 2019 Dec; 25(6):737-753.e4. PubMed ID: 31708402
[TBL] [Abstract][Full Text] [Related]
37. Human Ocular Epithelial Cells Endogenously Expressing SOX2 and OCT4 Yield High Efficiency of Pluripotency Reprogramming.
Poon MW; He J; Fang X; Zhang Z; Wang W; Wang J; Qiu F; Tse HF; Li W; Liu Z; Lian Q
PLoS One; 2015; 10(7):e0131288. PubMed ID: 26131692
[TBL] [Abstract][Full Text] [Related]
38. Differentiation of human embryonic stem cells along a hepatic lineage.
Zamule SM; Coslo DM; Chen F; Omiecinski CJ
Chem Biol Interact; 2011 Mar; 190(1):62-72. PubMed ID: 21241686
[TBL] [Abstract][Full Text] [Related]
39. Context-Dependent Functions of NANOG Phosphorylation in Pluripotency and Reprogramming.
Saunders A; Li D; Faiola F; Huang X; Fidalgo M; Guallar D; Ding J; Yang F; Xu Y; Zhou H; Wang J
Stem Cell Reports; 2017 May; 8(5):1115-1123. PubMed ID: 28457890
[TBL] [Abstract][Full Text] [Related]
40. mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.
Grace HE; Galdun P; Lesnefsky EJ; West FD; Iyer S
Stem Cells Dev; 2019 Jul; 28(13):846-859. PubMed ID: 31017045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]